Interaction of 5-methyl-urapidil with α1-adrenoceptors in canine blood vessels: Impact of pacing-induced heart failure

European Journal of Pharmacology

Volumn 318, Issue 1, 1996, Pages 55-63

  Forster, Christine ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

1 Adrenoceptor; 5 Methyl urapidil; Dorsal pedal artery; Heart failure; Saphenous vein; Ventricular pacing, rapid

Indexed keywords

5 METHYLURAPIDIL; ALPHA 1 ADRENERGIC RECEPTOR; NORADRENALIN; PHENYLEPHRINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG SENSITIVITY; HEART FAILURE; IN VITRO STUDY; LEG ARTERY; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN;

ANIMALS; ARTERIES; CARDIAC PACING, ARTIFICIAL; DOGS; HEART FAILURE, CONGESTIVE; HINDLIMB; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PHENYLEPHRINE; PIPERAZINES; RECEPTORS, ADRENERGIC, ALPHA-1; SAPHENOUS VEIN; VASOCONSTRICTOR AGENTS;

EID: 0030604272     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00750-9     Document Type: Article

References (54)

1. 1-adrenoceptor mediating contractions of the rat aorta, vas deferens and spleen, Br. J. Pharmacol. 109, 80.
2. Armstrong, P.W., T.P. Stopps, S.E. Ford and A.J. De Bold, 1986, Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure, Circulation 74, 1075.
3. Arunlakshana, O. and H.O. Schild, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. 14, 48.
4. 1-adrenoceptors, Eur. J. Pharmacol. 172, 131.
5. 1B-adrenoceptor mediating contraction of the rat spleen, Br. J. Pharmacol. 115, 467.
6. Bylund, D.B., D.C. Eikenberg, J.P. Hieble, S.Z. Langer, R.J. Lefkowitz, K.P. Minneman, P.B. Molinoff, R.R. Ruffolo Jr. and U. Trendelenberg, 1994, International Union of Pharmacology. IV. Nomenclature of adrenoceptors, Pharmacol. Rev. 46, 121.
7. 1-adrenoceptor classification scheme, Pharmacol. Commun. 6, 9.
8. Cody, R.J. and J.H. Laragh, 1988, The renin-angiotensin-aldosterone system in chronic heart failure: pathophysiology and implications for treatment, in: Drug Treatment of Heart Failure, ed. J.N. Cohn (Advanced Therapeutic Communications International, Secaucus, NJ) p. 79.
9. 1-adrenergic receptor, Proc. Natl. Acad. Sci. USA 85, 7159.
10. Daniel, E.E., A.M. Low, V. Gaspar, H, Lu-Chao, J. Green, J. Akrong, S. Duerksen, C. Soyka, C.K. Chen, J. Boyd and C.Y. Kwan, 1996, Unusual α-adrenoceptor subtype in canine saphenous vein: comparison to mesenteric vein, Br. J. Pharmacol. 117, 1535.
11. 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat, Eur. J. Pharmacol. 224, 125.
12. Flavahan, N.A. and P.M. Vanhoutte, 1986, α-Adrenoceptor subclassification in vascular smooth muscle, Trends Pharmacol. Sci. 7, 347.
13. 1-Adrenoceptor classification: sharpening Occam's razor, Trends Pharmacol. Sci. 15, 167.
14. Forster, C., 1995, Inhibition of vascular contractions to α-adrenoceptor agonists by polymyxin B: impact of heart failure state, Eur. J. Pharmacol. 283, 241.
15. Forster, C. and P.W. Armstrong, 1990, Pacing-induced heart failure in the dog: evaluation of peripheral vascular α-adrenoceptor subtypes, J. Cardiovasc. Pharmacol. 16, 708.
16. Forster, C. and P.M. Campbell, 1993, Nifedipine inhibits responses to α-adrenoceptor stimulation in canine blood vessels: impact of heart failure, Eur. J. Pharmacol. 242, 119.
17. 1B-adrenoceptors play a role in the exaggerated vascular response to α-agonists in experimental heart failure?, Br. J. Pharmacol. 119, 261.
18. 1-Adrenoceptor activity in arterial smooth muscle following congestive heart failure, Can. J. Physiol. Pharmacol. 67, 110.
19. Forster, C., S. Carter and P. Armstrong, 1989b, Vascular smooth muscle responsiveness to noradrenaline and phenylephrine following experimental heart failure in dogs, Cardiovasc. Res. 23, 489.
20. Forster, C., D. Wanes and P.W. Armstrong, 1991, Novel vascular effects of isoprenaline following pacing-induced heart failure in the dog, Eur. J. Pharmacol. 200, 251.
21. Forster, C., P.M. Campbell and P.W. Armstrong, 1992a, Temporal alterations in peripheral vascular responsiveness during both the development and recovery from pacing- induced heart failure, J. Cardiovasc. Pharmacol. 20, 206.
22. Forster, C., G. Larosa and P.W. Armstrong, 1992b, Impact of enalapril therapy on in vitro coronary artery responsiveness in pacing-induced heart failure, Can. J. Pysiol. Pharmacol. 70, 1417.
23. 1A-Adrenoceptor-mediated contractile responses of the human vas deferens, Br. J. Pharmacol. 116, 1605.
24. 3H-methylurapidil, Mol. Pharmacol. 44, 589.
25. 1-adrenoceptors, Eur. J. Pharmacol. 272, R5.
26. Goldsmith, S.R. and S.H. Kubo, 1988, Pathophysiology of heart failure: peripheral vascular factors and neurohormonal mechanisms, in: Drug Treatment of Heart Failure, ed. J.H. Cohn (Advanced Therapeutic Communications International, Secaucus, NJ) p. 49.
27. 1- adrenergic receptor subtypes, Pharmacol. Commun. 6, 15.
28. 1-adrenoceptor, Eur. J. Pharmacol. 151, 333.
29. ++ in smooth muscle, Nature 329, 333.
30. 1-adrenergic receptors revealed by chloroethylclonidine, Mol. Pharmacol. 32, 505.
31. Herlihy, J.T. and P.V. Berardo, 1986, Effect of preload on rat aortic smooth muscle sensitivity to vasoactive agents, Pharmacology 33, 39.
32. Hicks, P.E., M. Barras, G. Herman, P. Mauduit, J.M. Armstrong and B. Rossignol, 1991, α-Adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production, Br. J. Pharmacol. 102, 151.
33. Hieble, J.P., D.B. Bylund, D.E. Clarke, D.C. Eikenburg, S.Z. Langer, R.J. Lefkowitz, K.P. Minneman and R.R. Ruffolo Jr., 1995, International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors; concensus update, Pharmacol. Rev. 47, 267.
34. Jenkinson, D.H., E.A. Barnard, D. Hoyer, P.P.A. Humphrey, P. Leff and N.P. Shankly, 1995, International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology, Pharmacol. Rev. 47, 255.
35. 1D adrenoceptor on rat aorta, Br. J. Pharmacol. 114, 25P.
36. Larosa, G. and C. Forster, 1996, Coronary β-adrenoceptor function is modified by the endothelium in heart failure, J. Vasc. Res. 33, 62.
37. 1A-like receptor pharmacology, Neurosci. Abstr. 733, 2.
38. Lomasney, J.W., S. Cotecchia, R.J. Lefkowitz and M.G. Caron, 1991, Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure-function relationships, Biochim. Biophys. Acta 1095, 127.
39. Low, A.M., D.M. Bowdish, T.R. Prashad and V. Gaspar, 1994, Interactions of chloroethylclonidine with rauwolscine- and prazosin-sensitive adrenoceptors in dog saphenous vein, Br. J. Pharmacol. 113, 1263.
40. 1c-)adrenoceptor subtype, Br. J. Pharmacol. 115, 781.
41. Michel, M.C. and P.A. Insel, 1994, Comparison of the cloned and pharmacologically defined rat tissue alpha 1-adrenoceptor subtypes, Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 136.
42. 3H]prazosin binding, Mol. Pharmacol. 29, 49.
43. 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery, Jpn. J. Pharmacol. 57, 535.
44. 1-adrenoceptors, Pharmacol. Commun. 6, 23.
45. Oriowa, M.A. and R.R. Ruffolo Jr., 1992, Activation of a single alpha-1-adrenoceptor in rat aorta mobilizes intracellular and extracellular pools of calcium, Pharmacology 44, 139.
46. Parker, R.B. and D.R. Waud, 1971, Pharmacological estimation of drug receptor dissociation constants. Statistical evaluation. (i) Agonists, J. Pharmacol. Exp. Ther. 177, 1.
47. Parmley, W.W., 1985, Pathophysiology of congestive heart failure, Am. J. Cardiol. 55, 9A.
48. 1D-adrenergic receptor cDNA, Mol. Pharmacol. 40, 876.
49. 1 adrenoceptor subtypes, J. Pharmacol. Exp. Ther. 254, 982.
50. 1d subtype, Can. J. Physiol. Pharmacol. 72 (Suppl. 1), P31.1.008.
51. 1-adrenergic receptor subtype, J. Biol. Chem. 265, 8183.
52. 1-adrenoceptors of rabbit and rat liver membranes, Life Sci. 53, 177.
53. 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man, Eur. J. Pharmacol. 249, 307.
54. Watson, S. and D. Girdlestone, 1996, Receptor and ion channel nomenclature, Trends Pharmacol. Sci. Suppl. 1, 10.